News
Mounjaro, initially for type 2 diabetes, gains popularity for weight loss, yet users report severe side effects. Ellie Marie, ...
Medications taken for weight loss are starting to impact wedding planning — and perhaps nothing more than the dress fitting.
IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.
The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many patients are left with no good options. Blockbuster obesity and diabetes drugs — such as Wegovy, ...
Novo Nordisk has hired multiple lobbying firms to persuade lawmakers to take a harder line on companies producing versions of ...
The US Food and Drug Administration seized fake Ozempic injections. This happened on April 9, 2025. Novo Nordisk warned about ...
Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...
With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...
After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were previously selling the copycats.
Hims & Hers on Tuesday announced a collaboration with drugmaker Novo Nordisk to bundle Wegovy and a Hims & Hers membership on its telehealth platform.
In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering will launch this week ...
Experts share why a diet rich in plant-based, nutrient-dense foods is key to staying healthy when using medications that curb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results